The reiteration of a Buy rating and maintenance of a high price target by a reputable analyst like Gil Blum from Needham can instill confidence in investors and potentially drive up the stock price of Immunocore Holdings in the short term. The specific mention of the company and the optimistic price target highlight a positive outlook for the company's stock.